Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial

被引：1
|
作者：
Reni, M. [1 ]
Cereda, S. [1 ]
Aprile, G. [2 ]
Tronconi, M. C. [3 ]
Milandri, C. [4 ]
Passoni, P. [1 ]
Rognone, A. [1 ]
Balzano, G. [1 ]
Di Carlo, V. [1 ]
Villa, E. [1 ]
机构：
[1] Hosp San Raffaele, I-20132 Milan, Italy
[2] Univ Hosp Udine, Udine, Italy
[3] Ist Clin Humanitas Rozzano, Milan, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori Meldola, Forli, Italy
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71320-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [1] ADJUVANT PEFG (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) OR GEMCITABINE IN PANCREATIC CANCER: A RANDOMIZED PHASE II TRIAL
    Reni, Michele
    Cereda, Stefano
    Aprile, Giuseppe
    Tronconi, Maria Chiara
    Milandri, Carlo
    Saletti, Piercarlo
    Passoni, Paolo
    Rognone, Alessia
    Fugazza, Clara
    Ceraulo, Domenica
    Balzano, Gianpaolo
    Di Carlo, Valerio
    Villa, Eugenio
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [2] Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
    Reni, Michele
    Balzano, Gianpaolo
    Aprile, Giuseppe
    Cereda, Stefano
    Passoni, Paolo
    Zerbi, Alessandro
    Tronconi, Maria Chiara
    Milandri, Carlo
    Saletti, Piercarlo
    Rognone, Alessia
    Fugazza, Clara
    Magli, Alessandro
    Di Muzio, Nadia
    Di Carlo, Valerio
    Villa, Eugenio
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) : 2256 - 2263
  • [3] Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
    Michele Reni
    Gianpaolo Balzano
    Giuseppe Aprile
    Stefano Cereda
    Paolo Passoni
    Alessandro Zerbi
    Maria Chiara Tronconi
    Carlo Milandri
    Piercarlo Saletti
    Alessia Rognone
    Clara Fugazza
    Alessandro Magli
    Nadia Di Muzio
    Valerio Di Carlo
    Eugenio Villa
    [J]. Annals of Surgical Oncology, 2012, 19 : 2256 - 2263
  • [4] A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer
    Reni, M.
    Cereda, S.
    Aprile, G.
    Tronconi, M. C.
    Milandri, C.
    Passoni, P.
    Rognone, A.
    Balzano, G.
    Di Carlo, V.
    Villa, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
    Reni, M.
    Cereda, S.
    Galli, L.
    [J]. CANCER LETTERS, 2007, 256 (01) : 25 - 28
  • [6] Preliminary results of a phase II trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinorna
    Reni, M.
    Cereda, S.
    Dell'Oro, S.
    Passoni, P.
    Bonetto, E.
    Vigano, M.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 225 - 226
  • [7] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Vigano, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI51
  • [8] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Bonetto, E.
    Vigano, M. G.
    Passoni, P.
    Zerbi, A.
    Balzano, G.
    Nicoletti, R.
    Staudacher, C.
    Di Carlo, V.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 361 - 367
  • [9] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    M. Reni
    S. Cereda
    E. Bonetto
    M. G. Viganò
    P. Passoni
    A. Zerbi
    G. Balzano
    R. Nicoletti
    C. Staudacher
    V. Di Carlo
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59
  • [10] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Viganò, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 208S - 208S
12345